If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUR.L Regulatory News (SUR)

  • There is currently no data for SUR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options and Rule 2.9 Announcement

6 Jun 2023 16:52

RNS Number : 8544B
Sureserve Group PLC
06 June 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

For immediate release

6 June 2023

Sureserve Group plc

("Sureserve" or the "Company")

Exercise of Options and Rule 2.9 Announcement

Sureserve (AIM: SUR), the social housing energy services Group, announces that, further to the exercise of options, as part of the Company's various Share Option Schemes, it has issued and allotted, subject to admission to trading on AIM ("Admission"), 460,786 new ordinary shares of 10 pence each (the "New Ordinary Shares"). In line with the rules of the Share Option Schemes the New Ordinary Shares were issued at the following prices:

 

· 450,786 New Ordinary Shares at 32p

· 10,000 New Ordinary Shares at 40.75p

 

Application for admission of the New Ordinary Shares to trading on AIM has been made and dealings in the New Ordinary Shares are expected to commence at 8.00 a.m. on 8 June 2023 ("Admission"). The New Ordinary Shares will rank pari-passu with the Company's existing issued ordinary shares.

 

Rule 2.9 disclosure and Total Voting Rights

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code"), on Admission, the Company will have in issue 166,683,402 ordinary shares of 10 pence each ("Sureserve Shares") with no ordinary shares held in treasury. The International Securities Identification Number (ISIN) for the Company's ordinary shares is GB00BSKS1M86.

 

This figure of 166,683,402 Sureserve Shares may also be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

Unless otherwise defined, capitalised terms in this announcement have the same meaning as in the Rule 2.7 Announcement published on 21 April 2023.

 

Enquiries

Sureserve

Nick Winks, Chairman

Tel: +44 (0)20 3961 522

Peter Smith, Chief Executive Officer

Sameet Vohra, Chief Financial Officer

Evercore (Financial Adviser to Sureserve)

Dimitrios Georgiou

Wladimir Wallaert

Nirav Amlani

Alex Bennett

Tel: +44 (0)20 7653 6000

Shore Capital (Nominated Adviser and Broker)

Stephane Auton / Daniel Bush / Tom Knibbs (Corporate Advisory)

Tel: +44 (0)20 7408 4090

Fiona Conroy (Corporate Broking)

Camarco (Financial Public Relations)

Ginny Pulbrook

Tel: +44 (0)20 3757 4992

Rosie Driscoll

 

Disclaimer

Evercore Partners International LLP ("Evercore"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively as financial adviser to Sureserve and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than Sureserve for providing the protections afforded to clients of Evercore nor for providing advice in connection with the matters referred to herein. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Evercore in connection with this announcement, any statement contained herein, any offer or otherwise. Apart from the responsibilities and liabilities, if any, which may be imposed on Evercore by the Financial Services and Markets Act 2000 and successor legislation, or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Evercore nor any of its affiliates accepts any responsibility or liability whatsoever for the contents of this announcement, and no representation, express or implied, is made by it, or purported to be made on its behalf, in relation to the contents of this announcement, including its accuracy, completeness or verification of any other statement made or purported to be made by it, or on its behalf, in connection with Sureserve or the matters described in this announcement. To the fullest extent permitted by applicable law, Evercore and its affiliates accordingly disclaim all and any responsibility or liability whether arising in tort, contract or otherwise (save as referred to above) which they might otherwise have in respect of this announcement or any statement contained herein.

Shore Capital and Corporate Limited and Shore Capital Stockbrokers Limited (together or individually, "Shore Capital"), which are authorised and regulated by the Financial Conduct Authority in the United Kingdom, are acting as nominated adviser and corporate broker to Sureserve and no one else in connection with the matters referred to in this announcement and will not be responsible to anyone other than Sureserve for providing the protections afforded to clients of Shore Capital nor for providing advice in connection with the matters referred to in this announcement. Neither Shore Capital nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Shore Capital in connection with the matters referred to in this announcement.

 

Publication on website

In accordance with Rule 26.1 of the Code, a copy of this announcement will be made available (subject to certain restrictions relating to persons resident in restricted jurisdictions), free of charge, on the Company's website at www.sureservegroup.co.uk by no later than 12:00 noon on the business day following the date of this announcement. Neither the content of this website nor the content of any other website accessible from hyperlinks on such website is incorporated into, or forms part of, this announcement.

 

Disclosure Requirements of the Takeover Code

Under Rule 8.3(a) of the Takeover Code, any person who is interested in one per cent or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3:30pm (London time) on the tenth business day following the commencement of the offer period and, if appropriate, by no later than 3:30pm (London time) on the tenth business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in one per cent or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3:30pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFSERTIRIIV
Date   Source Headline
28th Jan 20213:07 pmRNSHolding(s) in Company
23rd Dec 20202:34 pmRNSBulletin Board Correction
23rd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 202012:13 pmRNSNotice of Preliminary Results
16th Nov 202011:15 amRNSNotification of Major Holdings
16th Nov 202011:13 amRNSGrant and vesting of awards
13th Nov 20209:12 amRNSExercise of Options and Total Voting Rights
3rd Nov 20204:58 pmRNSHolding(s) in Company
2nd Nov 202010:43 amRNSNotification of Major Holdings
14th Oct 202010:53 amRNSExercise of Options and Total Voting Rights
13th Oct 20201:07 pmRNSHolding(s) in Company
6th Oct 202012:07 pmRNSExercise of Options and Total Voting Rights
6th Oct 20207:00 amRNSPost year-end trading update
7th Sep 20209:47 amRNSExercise of Options and Total Voting Rights
4th Sep 20209:40 amRNSTransaction by Directors / PDMR
1st Sep 20203:25 pmRNSHolding(s) in Company
19th Aug 20207:00 amRNSTrading Update: Delivering a strong performance
13th Aug 20209:10 amRNSExercise of Options and Total Voting Rights
3rd Jul 20203:14 pmRNSExercise of Options and Total Voting Rights
16th Jun 20202:32 pmRNSExercise of Options and Total Voting Rights
8th Jun 20203:02 pmRNSExercise of options and admission to trading
27th May 20207:00 amRNSInterim Results
21st May 20207:00 amRNSExercise of options and admission to trading
7th May 20207:00 amRNSExercise of options and admission to trading
30th Mar 20207:00 amRNSCOVID-19 Update and Dividend Payment Confirmation
18th Mar 202010:46 amRNSResult of AGM
18th Mar 20207:00 amRNSAGM Statement
20th Feb 20207:00 amRNSPosting of Annual Report and Notice of AGM
20th Feb 20207:00 amRNSPosting of Annual Report and Notice of AGM
21st Jan 20207:00 amRNSPreliminary Results
25th Nov 20195:15 pmRNSDirector Dealing
23rd Oct 20197:00 amRNSNet debt position
4th Oct 20197:00 amRNSPost year end trading update and Board changes
25th Jun 20197:00 amRNSDirectorate change
25th Jun 20197:00 amRNSInterim Results for the six months ended 31 March
24th Jun 20192:41 pmRNSChange of Adviser
24th Jun 201911:29 amRNSDirectors' disclosures
21st May 201912:44 pmRNSDirector/PDMR Shareholding
21st May 20197:00 amRNSHolding(s) in Company
16th May 20192:30 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSChange of Registered Office
15th Apr 20197:00 amRNSExercise of options
19th Mar 20191:26 pmRNSDirector Disclosure
19th Mar 201911:08 amRNSResults of AGM
18th Mar 201912:14 pmRNSDirectorate Change
12th Mar 201911:38 amRNSHolding(s) in Company
7th Mar 20192:25 pmRNSHolding(s) in Company
21st Feb 20197:00 amRNSPosting of Annual Report and Notice of AGM
22nd Jan 20197:00 amRNSPreliminary Results
9th Jan 20194:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.